Clincosm LogoSign in Get a demo

locally advanced malignant solid neoplasm

Showing 1 - 17 of 17
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematopoietic and Lymphoid System Tumor, Locally Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor Trial in

Not yet recruiting
  • Hematopoietic and Lymphoid System Neoplasm
  • +2 more
  • Best Practice
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 29, 2022

Advanced Malignant Solid Tumor, Locally Advanced Malignant Solid Tumor Trial (Binimetinib, Biopsy, Biospecimen Collection)

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • Locally Advanced Malignant Solid Neoplasm
  • (no location specified)
Sep 29, 2022

Locally Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial (Biopsy,

Not yet recruiting
  • Locally Advanced Malignant Solid Neoplasm
  • +2 more
  • Biopsy
  • +5 more
  • (no location specified)
Sep 28, 2022

Solid Tumors, Adult, PIK3CA Mutation-Related Tumors, PIK3CA Mutation Trial in San Francisco (Alpelisib, Carboplatin,

Not yet recruiting
  • Solid Tumors, Adult
  • +7 more
  • San Francisco, California
    University of California, San Francisco
Jul 21, 2022

Adoption of Audio Recording in Outpatient Supportive Care Center

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • +4 more
  • Communication Intervention
  • Questionnaire Administration
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +14 more
  • Biopsy
  • +25 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jul 12, 2022

Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IV Gastroesophageal Junction Adenocarcinoma

Recruiting
  • Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
  • +33 more
  • Communication Intervention
  • +2 more
  • New York, New York
  • +3 more
Jun 29, 2022

Distress Associated With Coronavirus Disease 2019 and Telehealth

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +6 more
  • Survey Administration
  • Houston, Texas
    M D Anderson Cancer Center
Jun 27, 2022

Locally Advanced Malignant Solid Tumor, Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in United

Recruiting
  • Locally Advanced Malignant Solid Neoplasm
  • +3 more
  • Agonistic Anti-OX40 Monoclonal Antibody INCAGN01949
  • VLP-encapsulated TLR9 Agonist CMP-001
  • Scottsdale, Arizona
  • +3 more
Jun 1, 2022

Locally Advanced Malignant Solid Tumor, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Solid Tumor Trial

Withdrawn
  • Locally Advanced Malignant Solid Neoplasm
  • +3 more
  • (no location specified)
May 24, 2022

Advanced Malignant Solid Tumor, Locally Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor Trial in San Francisco

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Support Group Therapy
  • +3 more
  • San Francisco, California
    University of California, San Francisco
May 12, 2022

Locally Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor Trial in Houston (Larotrectinib Sulfate)

Recruiting
  • Locally Advanced Malignant Solid Neoplasm
  • Metastatic Malignant Solid Neoplasm
  • Larotrectinib Sulfate
  • Houston, Texas
    M D Anderson Cancer Center
Apr 18, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +129 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Apr 8, 2022

Locally Advanced Malignant Solid Tumor Trial in Houston (Pembrolizumab)

Recruiting
  • Locally Advanced Malignant Solid Neoplasm
  • Pembrolizumab
  • Houston, Texas
    M D Anderson Cancer Center
Mar 22, 2022

Advanced Malignant Tumor, ALK Fusion Protein Expression, ALK Gene Amplification Trial in Columbus (Brigatinib, Laboratory

Withdrawn
  • Advanced Malignant Neoplasm
  • +10 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Feb 15, 2022

Locally Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in Houston

Active, not recruiting
  • Locally Advanced Malignant Solid Neoplasm
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 18, 2022

Aggressive Non-Hodgkin Lymphoma, Indolent Non-Hodgkin Lymphoma, Locally Advanced Malignant Solid Tumor Trial run by the NCI (p97

Withdrawn
  • Aggressive Non-Hodgkin Lymphoma
  • +3 more
  • p97 Inhibitor CB-5339 Tosylate
  • Bethesda, Maryland
  • +1 more
Aug 27, 2021